MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

successful trial results for world-first obesity d, page-3

  1. 131 Posts.
    after years of waiting looks like patience has won!
    I expect a few apologies here for all the flack i received over the years on MBP, the company has indicated by all past test results that they were going into a positive outcome and this is a huge hoorah for australian biotechnology
    We should see a run in other biotechs today, with australia going on the world biotech map
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.